240 related articles for article (PubMed ID: 38613798)
21. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
22. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-
Tang Y; Ding F; Wu C; Liu B
Anal Cell Pathol (Amst); 2021; 2021():6653681. PubMed ID: 34426780
[TBL] [Abstract][Full Text] [Related]
23. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
Yang H; Lv H; Li H; Ci X; Peng L
Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
[TBL] [Abstract][Full Text] [Related]
24. Exocarpium Citri Grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis.
Xu Z; Li J; Zhou K; Wang K; Hu H; Hu Y; Gao Y; Luo Z; Huang J
J Ethnopharmacol; 2024 Jul; 329():118162. PubMed ID: 38588989
[TBL] [Abstract][Full Text] [Related]
25. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
Li J; Ma J; Li M; Tao J; Chen J; Yao C; Yao S
Life Sci; 2021 Apr; 271():119192. PubMed ID: 33577850
[TBL] [Abstract][Full Text] [Related]
26. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
27. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of curcumin in acute lung injury: In vivo and in vitro experimental model studies.
Wang Y; Wang Y; Cai N; Xu T; He F
Int Immunopharmacol; 2021 Jul; 96():107600. PubMed ID: 33798807
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
Tian L; Li W; Wang T
Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
[TBL] [Abstract][Full Text] [Related]
30. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
Wang C; Zeng L; Zhang T; Liu J; Wang W
Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
Zhou Y; Li QX; Liao ZZ; Liu Y; Ouyang Y; Jiang WJ; Tang MT; Hu JF; Zhang W
J Ethnopharmacol; 2023 Dec; 317():116763. PubMed ID: 37315646
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effect of Mahaenggamseok-tang on neutrophilic lung inflammation is associated with NF-κB suppression and Nrf2 activation.
Kim KH; Lee JY; Kwun MJ; Choi JY; Han CW; Ha KT; Jeong SI; Jeong HS; Joo M
J Ethnopharmacol; 2016 Nov; 192():486-495. PubMed ID: 27660010
[TBL] [Abstract][Full Text] [Related]
34. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
[TBL] [Abstract][Full Text] [Related]
35. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
36. Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3/STAT3 pathway.
Jiang W; Ren J; Li X; Yang J; Cheng D
Int Immunopharmacol; 2024 May; 132():111931. PubMed ID: 38547769
[TBL] [Abstract][Full Text] [Related]
37. NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury.
Li R; Zhao Y; Zhang X; Yang L; Zou X
Immunol Invest; 2023 Nov; 52(5):567-582. PubMed ID: 37139806
[TBL] [Abstract][Full Text] [Related]
38. Eriodictyol ameliorates lipopolysaccharide-induced acute lung injury by suppressing the inflammatory COX-2/NLRP3/NF-κB pathway in mice.
Wang X; Deng R; Dong J; Huang L; Li J; Zhang B
J Biochem Mol Toxicol; 2020 Mar; 34(3):e22434. PubMed ID: 31860763
[TBL] [Abstract][Full Text] [Related]
39. NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting TXNIP/NLRP3 and NF-κB.
Fang XZ; Ge YL; Chen ZY; Shu HQ; Yang YY; Yu Y; Zhou XJ; Chen L; Cui SN; Wang YX; Yao SL; Shang Y
Int Immunopharmacol; 2020 Apr; 81():106257. PubMed ID: 32044659
[TBL] [Abstract][Full Text] [Related]
40. Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
Wen H; Lu D; Chen H; Zhu Y; Xie Q; Zhang Z; Wu Z
Drug Dev Res; 2022 Sep; 83(6):1362-1372. PubMed ID: 35976115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
